These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 24240044)
21. Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection. Askar E; Ramadori G; Mihm S J Med Virol; 2010 Nov; 82(11):1859-68. PubMed ID: 20872712 [TBL] [Abstract][Full Text] [Related]
22. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients. Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957 [TBL] [Abstract][Full Text] [Related]
23. A study of some hepatic immunological markers, iron load and virus genotype in chronic hepatitis C. Cardoso EM; Duarte MA; Ribeiro E; Rodrigues P; Hultcrantz R; Sampaio P; Ehrlich R; Carvalho J; Fraga J; de Sousa M J Hepatol; 2004 Aug; 41(2):319-26. PubMed ID: 15288483 [TBL] [Abstract][Full Text] [Related]
24. RNA protein kinase SNP at -226 CWahid A; Hamzawy MA; Khalifa MMA; Gad GFM; Bekhit A; Abdelwahab SF Immunol Invest; 2019 Apr; 48(3):211-221. PubMed ID: 30080984 [TBL] [Abstract][Full Text] [Related]
25. The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy. Pang PS; Planet PJ; Glenn JS PLoS One; 2009 Aug; 4(8):e6579. PubMed ID: 19668364 [TBL] [Abstract][Full Text] [Related]
26. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Hijikata M; Ohta Y; Mishiro S Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132 [TBL] [Abstract][Full Text] [Related]
27. Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4. Shaker O; Nassar Y; Ayoub S; Elrazki M; Zahra A J Clin Lab Anal; 2016 Nov; 30(6):1021-1027. PubMed ID: 27087054 [TBL] [Abstract][Full Text] [Related]
28. [Investigation of IL-1 beta, IL-1 receptor antagonist and IL-8 gene polymorphisms in patients with chronic hepatitis B and C]. Borekci G; Karakas Celik S; Kandemir O; Aras N; Yalin S Mikrobiyol Bul; 2014 Apr; 48(2):271-82. PubMed ID: 24819264 [TBL] [Abstract][Full Text] [Related]
29. Innate Immunity in Hepatitis C Virus Infection. Schwerk J; Negash A; Savan R; Gale M Cold Spring Harb Perspect Med; 2021 Feb; 11(2):. PubMed ID: 32341066 [TBL] [Abstract][Full Text] [Related]
30. Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil. Vigani AG; Pavan MH; Tozzo R; Gonçales ES; Feltrin A; Fais VC; Lazarini MS; Gonçales NS; Gonçales FL BMC Infect Dis; 2008 Dec; 8():164. PubMed ID: 19055835 [TBL] [Abstract][Full Text] [Related]
31. Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients. Chowdhury SJ; Karra VK; Bharali R; Kar P J Viral Hepat; 2015 Aug; 22(8):671-4. PubMed ID: 25573496 [TBL] [Abstract][Full Text] [Related]
32. [Correlation between hepatic immunological markers and virus genotype in patients with chronic hepatitis C]. Yu WH; Li WX; Zhou DQ; He JS; Dong JM; Song ZX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):452-5. PubMed ID: 16883540 [TBL] [Abstract][Full Text] [Related]
33. Racial differences in response to interferon-based antiviral therapy for hepatitis C virus infection: a hardwiring issue? Tai AW; Chung RT J Infect Dis; 2009 Apr; 199(8):1101-3. PubMed ID: 19284288 [No Abstract] [Full Text] [Related]
38. Response to commentary article: "The association between Interleukin-1β gene rs1143634 polymorphism and the risk of breast cancer by Bei Wang, Fenlai Yuan". Pooja S; Rajender S; Konwar R Cytokine; 2019 Jan; 113():477. PubMed ID: 30075887 [TBL] [Abstract][Full Text] [Related]
39. Relationship between the polymorphism in the interleukin 1-β and the treatment time of patients subjected to a modified piezocision technique. Aristizábal JF; Rios H; Rey D; Álvarez MA; Parra B; Ortiz M Colomb Med (Cali); 2020 Mar; 51(1):e4141. PubMed ID: 32952230 [TBL] [Abstract][Full Text] [Related]